(Q40033522)
Statements
1 reference
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinib (English)
1 reference
Matthew Meyerson
1 reference
Pasi A Jänne
1 reference
John V Heymach
1 reference
Jeffrey A Engelman
1 reference
Kreshnik Zejnullahu
1 reference
Christopher-Michael Gale
1 reference
Eugene Lifshits
1 reference
Andrea J Gonzales
1 reference
Takeshi Shimamura
1 reference
Feng Zhao
1 reference
Patrick W Vincent
1 reference
George N Naumov
1 reference
James E Bradner
1 reference
Irene W Althaus
1 reference
Geoffrey I Shapiro
1 reference
James M Nelson
1 reference
Kwok-Kin Wong
1 reference
1 December 2007
1 reference
1 reference
67
1 reference
24
1 reference
11924-11932
1 reference
Identifiers
1 reference
1 reference